Mutations in TP53 are found in the majority of HPVneg head and neck tumors and were shown to affect survival, also in hypopharyngeal cancer; specifically, truncating mutations (frameshift, nonsense, splice-site) seem to be associated with poorer outcome (55, 56). Here, TP53 is linked to hypopharynx cancer.